Conducts translational research to prevent and treat disorders of pulmonary transition such as birth asphyxia, persistent pulmonary hypertension of the newborn (PPHN), transient tachypnea of the newborn (TTN) and respiratory distress syndrome (RDS).
Research encompasses neurobiology of children with autism spectrum disorders; concurrent seizure disorders; epileptiform abnormalities; etiology; screening and evaluation techniques.
Has participated in more than 40 clinical trials and has helped bring several drugs through development to clinical use for patients with CF, focusing on inhaled antibiotics, mucoactive drugs and CFTR potentiators and correctors.
